Including New Indices and a New Exam to Assess the Impact of Dry Eye, “iTrace Prime” Puts More Information in One Place for Cataract and Refractive Surgeons
HOUSTON–(BUSINESS WIRE)–Tracey Technologies announced the release of iTrace Prime, an upgraded software for the iTrace Ray Tracing Aberrometer and Corneal Topographer from a trusted leader in ophthalmic technology development. This new software version (7.0) adds many valuable new features that improve the range of information able to be gathered from a single device.
The “Prime Dashboard” includes two new indices: the Corneal Performance Index (CPI™) and the Quality of Vision Index (QVI™) to the proprietary Dysfunctional Lens Index (DLI™). This additional data provides practitioners an even more comprehensive picture of patients’ eyesight while enhancing their ability to identify the source of vision problems, making it easier to plan the best treatment option for every patient.
The iTrace Prime upgrade also includes Tear Film Analysis, a new capability that surgeons have been waiting for. This latest addition to iTrace will record many images of the ocular surface for 12 seconds starting immediately after a blink, which can then reveal the local shape and sharpness changes of Placido rings. A proprietary algorithm then generates a number from 0-10 — the Tear Film Index (TFI™) — which assesses the degree to which the effects of Dry Eye Disease (DED) are impacting a patient’s vision.
“We’re proud to continue developing iTrace capabilities as we stay at the leading edge of the vision industry,” said Ray Sievert, Tracey’s Executive Vice President of Sales and Marketing. “The quality and stability of the ocular surface is a critical component of understanding a patient’s vision issues as we strive to help surgeons provide exceptional outcomes after eye surgery. We’re proud that iTrace Prime is making it possible for doctors to utilize even more needed information from a single device.”
About the iTrace
Tracey Technologies developed the iTrace more than a decade ago to help uncover the underlying causes of “vision mysteries,” educate patients, and precisely plan a range of vision correction procedures. As the only device to use true Ray Tracing to objectively measure the way light enters the eye, top cataract and refractive surgeons have relied on the iTrace to help them provide the best possible outcomes to their patients for many years. To learn more about the iTrace, visit www.traceytechnologies.com.